انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
Manage episode 446396660 series 3256997
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:
- 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D
- The role of bispecific antibodies in R/R MM
- Safety considerations for patients while receiving a bispecific antibody
- Emerging data and clinical trials with bispecific antibodies
- Key clinical pearls for optimal use of bispecific antibodies
Presenter:
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
La Jolla, California
Link to full program:
https://bit.ly/40bjFCZ
186 حلقات
Manage episode 446396660 series 3256997
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:
- 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D
- The role of bispecific antibodies in R/R MM
- Safety considerations for patients while receiving a bispecific antibody
- Emerging data and clinical trials with bispecific antibodies
- Key clinical pearls for optimal use of bispecific antibodies
Presenter:
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
La Jolla, California
Link to full program:
https://bit.ly/40bjFCZ
186 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.